Member Info for MrBB

Pity Leicester were knocked out last night but good to see our sponsorship of the AM shirts being beamed around the world to football fans.

Where have his interesting & informative posts gone ?

Should result in more volatility & therefore more business for us ?

Their generic version of Advair was held up by the FDA yesterday & The Market maybe concerned that 10th May wont go well for Hikma/Vec.Good news for GSK as no generic competition as yet but let us hope that our product is approved giving us an advantage over Mylan until ( & if) they can get their product through after adjustments

I started buying at under 10p when JG first became involved,expecting the shake up & diversification which eventually came.The profits warning earlier this ( together with the large bad debt last year) dented confidence & interrupted our slow but steady recovery.My average cost is about 11p per share & the current yield ( assuming held) is just under 6% ( at current prices.I did not & do not expect my investment here to be stellar but as JG diversifies our small group I would hope that he will ,one day, be made an offer which he will accept, retire gracefully into the sunset & ,over time, provide me with some capital growth & a steadily increasing yield.disappointed that a tradfing update was not included in todays RNS as I dont think that one small extra paragraph would have been too demanding on their time & may have comforted we investors that we are back on track & the problem division is beingturned around.The lack of comment could be interpreted negatively.

Very positive news & will hopefully prove your re entry here,CS,to have been very well timed.Pity JG did not see fit to provide a trading update with the RNS,as our year ends in 5 weeks & ,if positive,would have helped our SP recover.

My only regret here is not having more shares !

I would have preferred the uncertainty over the legal claim against SKP to have been resolved but news of expected progress in respect of our China JV & deals with Hikma & others keeps me interested here & I am not planning on selling any of my shares here.I am interested in broker forecasts & whether there may be any upgrades.Our SP has missed out totally on the post Brexit /Trump rallies & I am hoping that continued good news over the remainder of this year could see our SP approaching the consensus of broker targets which will hopefully be upgraded as the news flows. I have to say that I am an optimist...unlike Mr Fed Up -who is probably fed up today

You guys need to be more ambitious-2018 seems a long way off-although you could,of course, be right !

Ahead of results next Friday & I am expecting a decent dividend for the quarter based on what should have been strong trading

I am hoping for 200p in the afterglow of the Results ,presentations & broker/analyst meetings -ever the optimist-thats me !

increase in our SP ahead of Results next Tuesday & I am hoping that there will be some fire with this smoke when all is revealed next week.It would be great to hear that our dispute with GSK has been settled amicably , & in our favour,Novartis have announced a major new deal involving us & positive trial news emerges from China-apart from continued growth in Flutiform-I may be expecting too much.

To see staff adverts referring positively to roles within our moulding business but we must remember that it was only the end of Jan the the RNS was issued advising as to how dire trade had been in moulding, culminating in the exit of our CEO & FD & it is doubtful whether JG could have turned it around this quickly.Encouraging to receive the dividend earlier this week & on a worse case scenario that would have been shelved.I am not hopefully of a trading update any time soon but it would be good to know if moulding is in the process of improving substantially.

We all markets hate uncertainty & I consider that our SP would benefit from a definitive deal between us & Astor enabling us to invest or pay dividends as we see fit.Presumably our cornerstone investors will voice their opinion to Alberto & if they prefer dividends sooner they will encourage a deal ,maybe involving some new shares & a fixed term loan.All ,of course, also depends on Cu remaining firm.

I appreciate that the Rns looks like the prelude to a placing ( which it might be) & provide a useful opportunity for Hambro to unload a large holding -but surely our Nomad must have due diligence before allowing such a "blue sky" RNS, by which I dont mean just accepting Director s assurances but by reviewing documentation between Blur & our prospective global client.I happened to buy low in Nov ( due to Mr Keiths interest ) & i am not selling for now. Why issue the Rns now ,if the contract is likely to be signed soon,unless a placing is imminent?Even if there is a placing we are unlikely to be offered any shares so whoever may support the placing would be "Inside" & fully understand what they are supporting. Fascinating !

If there is to be a placing,which I agree will be likely at some point, I would hope it would be accompanied by tangible contract news rather than news about very exciting hoped for news-which could transpire to be false news - so perhaps DT will take a substantial holding ( if allowed by Congress)

By the end of todays trading I would expect that volume will exceed the free float & it will be interesting to see if the buying continues or those buying early this morning will cash out.as dubious as I am my stake will not be sold into this spike as i am curious to see where we are going.

for me so far-if we hold up !Perhaps our new investor,a few weeks ago,who tempted me in at just over 5p, knew what was going on behind the scenes.it will be interesting to see if the multi million £ deal ever materialises but I wont be selling until we know.

We should be delighted with the rapid & successful turnaround achieved by Mark Braund & his team.Having invested in Coms towards the end of its life I,at one stage had a loss here of over 95% & following purchases of Reds at various levels I find myself in profit & invested in a company which seems to be doing very well-which is gratifying for me & ,I am sure, many other holders

Presumably to create more flexibility in respect of the payment of dividends.